UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1259-1266

2016

Volltextzugriff (PDF)

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

Nephrology, dialysis, transplantation, 2019-01, Vol.34 (1), p.63-73

2019

Volltextzugriff (PDF)

Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing

Journal of Crohn's and colitis, 2024-08, Vol.18 (7), p.1081-1090

2024

Volltextzugriff (PDF)

Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients

Rheumatology (Oxford, England), 2012-03, Vol.51 (3), p.557-561

2012

Volltextzugriff (PDF)

Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment

Journal of Crohn's and colitis, 2016-11, Vol.10 (11), p.1279-1286

2016

Volltextzugriff (PDF)

The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD

Inflammatory bowel diseases, 2019-01, Vol.25 (1), p.142-149

2019

Volltextzugriff (PDF)

The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios

Inflammatory bowel diseases, 2019-04, Vol.25 (5), p.919-924

2019

Volltextzugriff (PDF)

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Inflammatory bowel diseases, 2017-10, Vol.23 (10), p.1873-1881

2017

Volltextzugriff (PDF)

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Inflammatory bowel diseases, 2017-11, Vol.23 (11), p.2011-2017

2017

Volltextzugriff (PDF)

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity

Journal of Crohn's and colitis, 2016-01, Vol.10 (1), p.61-68

2016

Volltextzugriff (PDF)

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2019-07, Vol.13 (7), p.838-845

2019

Volltextzugriff (PDF)

Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2017-02, Vol.11 (2), p.175-184

2017

Volltextzugriff (PDF)

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid‐dependent Crohn's disease

Inflammatory bowel diseases, 2009-03, Vol.15 (3), p.375-382

2009

Volltextzugriff (PDF)

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

Inflammatory bowel diseases, 2011-06, Vol.17 (6), p.1301-1307

2011

Volltextzugriff (PDF)

Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]

Journal of Crohn's and colitis, 2019-09, Vol.13 (9), p.1097-1104

2019

Volltextzugriff (PDF)

The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE

Rheumatology (Oxford, England), 2010-04, Vol.49 (4), p.723-732

2010

Volltextzugriff (PDF)

Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease

Inflammatory bowel diseases, 2017-01, Vol.23 (1), p.126-132

2017

Volltextzugriff (PDF)

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone

Inflammatory bowel diseases, 2017-06, Vol.23 (6), p.946-955

2017

Volltextzugriff (PDF)

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry

Journal of Crohn's and colitis, 2020-09, Vol.14 (9), p.1290-1298

2020

Volltextzugriff (PDF)

Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study

Inflammatory bowel diseases, 2017-02, Vol.23 (2), p.261-271

2017

Volltextzugriff (PDF)

Medication Adherence and Quality of Life in Pediatric Inflammatory Bowel Disease

Journal of pediatric psychology, 2008-09, Vol.33 (8), p.867-874

2008

Volltextzugriff (PDF)

Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen

Rheumatology (Oxford, England), 2012-03, Vol.51 (3), p.476-481

2012

Volltextzugriff (PDF)

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

Inflammatory bowel diseases, 2008-07, Vol.14 (7), p.949-954

2008

Volltextzugriff (PDF)

Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD

Journal of Crohn's and colitis, 2010-10, Vol.4 (4), p.444-449

2010

Volltextzugriff (PDF)

Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions

Inflammatory bowel diseases, 2015-04, Vol.21 (4), p.832-839

2015

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(114)

Publikationsform

Artikel
(116)

Sprache

Englisch
(116)

Erscheinungsjahr

n.n

Thema

Humans
(115)
Life Sciences & Biomedicine
(102)
Science & Technology
(102)
Female
(86)
Male
(82)
Azathioprine - Administration & Dosage
(79)
Adult
(75)
Gastroenterology & Hepatology
(70)
Middle Aged
(64)
Immunosuppressive Agents - Administration & Dosage
(58)
Azathioprine - Therapeutic Use
(45)
Immunosuppressive Agents - Therapeutic Use
(45)
Treatment Outcome
(43)
Azathioprine
(37)
Crohn Disease - Drug Therapy
(36)
Drug Therapy, Combination
(33)
Adolescent
(30)
Retrospective Studies
(30)
Aged
(29)
Azathioprine - Adverse Effects
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis

Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing

Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients

Mucosal Healing in Paediatric Patients with Moderate-to-Severe Luminal Crohn’s Disease Under Combined Immunosuppression: Escalation versus Early Treatment

The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD

The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios

More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing

Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?

Azathioprine-induced Acute Pancreatitis in Patients with Inflammatory Bowel Diseases—A Prospective Study on Incidence and Severity

Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease

Early Assessment of Thiopurine Metabolites Identifies Patients at Risk of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid‐dependent Crohn's disease

Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease

Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study]

The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE

Development and Internal Validation of a Model Using Fecal Calprotectin in Combination with Infliximab Trough Levels to Predict Clinical Relapse in Crohn's Disease

Azathioprine with Allopurinol: Lower Deoxythioguanosine in DNA and Transcriptome Changes Indicate Mechanistic Differences to Azathioprine Alone

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry

Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study

Medication Adherence and Quality of Life in Pediatric Inflammatory Bowel Disease

Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD

Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions

Aktive Filter

Suchergebnisse filtern